Nora Therapeutics Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Nora Therapeutics General Information

Description

Provider of biotechnology platform intended to develop therapeutics to address unmet needs in reproductive medicine. The company's platform develops therapeutics to address IVF failure and recurrent pregnancy loss in women who have a history of unexplained recurrent miscarriage, enabling physicians to help their patients in embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 530 Lytton Avenue
  • 2nd floor
  • Palo Alto, CA 94301
  • United States
+1 (650)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Therapeutic Devices
Vertical(s)
Corporate Office
  • 530 Lytton Avenue
  • 2nd floor
  • Palo Alto, CA 94301
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nora Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Jan-2017 Completed Out of Business
3. Later Stage VC 13-Oct-2015 Completed Generating Revenue
2. Later Stage VC (Series B) 17-Apr-2014 $18M $52.9M Completed Generating Revenue
1. Later Stage VC (Series A) 01-Sep-2010 $34.9M $34.9M Completed Product Development
To view Nora Therapeutics’s complete valuation and funding history, request access »

Nora Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Nora Therapeutics’s complete cap table history, request access »

Nora Therapeutics Patents

Nora Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015057724-A1 Use of g-csf for treating or preventing villitis of unknown etiology in a human female Inactive 14-Oct-2013
WO-2010126528-A1 Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination Inactive 01-May-2009
WO-2010126528-A9 Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination Inactive 01-May-2009
WO-2010126553-A1 Compositions and methods for reducing the likelihood of implantation failure or spontaneous abortion in recipients of assisted reproduction Inactive 01-May-2009
EP-2274325-A1 Human g-csf analogs and methods of making and using thereof Inactive 13-May-2008 C07K14/535
To view Nora Therapeutics’s complete patent history, request access »

Nora Therapeutics FAQs

  • When was Nora Therapeutics founded?

    Nora Therapeutics was founded in 1992.

  • Where is Nora Therapeutics headquartered?

    Nora Therapeutics is headquartered in Palo Alto, CA.

  • What industry is Nora Therapeutics in?

    Nora Therapeutics’s primary industry is Pharmaceuticals.

  • Is Nora Therapeutics a private or public company?

    Nora Therapeutics is a Private company.

  • What is Nora Therapeutics’s current revenue?

    The current revenue for Nora Therapeutics is .

  • How much funding has Nora Therapeutics raised over time?

    Nora Therapeutics has raised $53.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process